NDC 83027-0156-01 — Virex Adenoviren Nosode, Asclepias Tuberosa

🆔 Identity & classification

FDA NDC (as labeled) 83027-0156-1

Product NDC 83027-0156

11-digit billing NDC 83027015601

UNII 1ZL82U5D18, QI7G114Y98, 4JS0838828, 451W47IQ8X, 11E6VI8VEG, C9642I91WL +12 more

UPC 0649818024176

SPL Set ID 4baa5c95-79a6-4ae8-a8c4-1edbf308f92c

Established class (EPC) Non-Standardized Food Allergenic Extract

Physiologic effect Increased Histamine Release; Cell-mediated Immunity

Chemical class Allergens; Dietary Proteins; Milk Proteins

DEA schedule Non-controlled

Marketing category UNAPPROVED HOMEOPATHIC

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 2025-10-03

Route ORAL

Dosage form SPRAY

Substance ASCLEPIAS TUBEROSA ROOT; ECHINACEA PURPUREA WHOLE; TRIFOLIUM PRATENSE FLOWER; SODIUM CHLORIDE; PHYTOLACCA AMERICANA ROOT; EUPHRASIA STRICTA; COW MILK; THUJA OCCIDENTALIS LEAFY TWIG; CALCIUM ARSENATE; CAMPHOR (NATURAL); INFLUENZA A VIRUS A/VICTORIA/4897/20

Why two NDCs? The FDA registers this code as 83027-0156-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 83027-0156-01. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerNutritional Specialties, Inc.

Labeler code83027

First marketedOct 2025

Product typeHuman Otc Drug

Portfolio162 products on file

🔎 All NDCs from Nutritional Specialties, Inc.

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Virex Adenoviren Nosode is an unapproved homeopathic oral spray containing plant extracts, minerals, and viral antigens used in homeopathic practice. Asclepias tuberosa, echinacea, and euphrasia are traditionally used in herbal medicine for respiratory and immune support, while camphor and calcium arsenate are common homeopathic ingredients. The product also contains antigens from human adenovirus and coxsackievirus strains prepared according to homeopathic methods. Homeopathic products are marketed based on traditional use and have not been evaluated by the FDA for safety or effectiveness.

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.

Where does this data come from?

Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per mL	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
Virex 3 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 6 [hp_X]/mL; 6 [hp_X]/mLthis 83027-0156-01	Nutritional	60 ml	—	—	FDA listed	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

2025

On the market since

Oct 2025

📍

2026

Currently FDA-listed

1 year listed

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Virex (this brand).

Top reported reactions

Aids Encephalopathy1

Finger Deformity1

Haemoglobin Decreased1

Lymphocyte Count Increased1

Muscle Spasms1

Opportunistic Infection1

Platelet Count Decreased1

Reporter sex

Male · 67%

Female · 33%

Serious outcomes

Death1

Reports over time (by year) — tap or hover for the count & year

Most recent year is provisional (FAERS lags ~3 months).

Where does this data come from?

Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
83027-0156-01 You're viewing this	60 mL in 1 BOTTLE, SPRAY (83027-0156-1)	2025-10-03	Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Virex Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Noso 3 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 6 [hp_X]/mL; 6 [hp_X]/mL SPRAY is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	— Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured)	— Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 83027-0156-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 83027-0156-01, written without dashes as 83027015601. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 83027-0156-01, the first segment (83027) is the labeler code FDA assigned to Nutritional Specialties, Inc.; the middle segment (0156) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.

Is this package still being marketed?

Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Nutritional Specialties, Inc.. Listing status can change — the directory data on this page refreshes weekly.

Who lists this product with the FDA?

Nutritional Specialties, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 34 words ▾

USES: Aids in temporary relief of symptoms including chills, sweats, occasional headaches, minor aches of muscles and joints, and runny nose. †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

⏱️ Dosage and Administration 45 words ▾

DIRECTIONS: • Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. • Do not take within 15 minutes of consuming food, beverage or brushing teeth. • Consult a physician for use in children under 12 years of age.

⚠️ Warnings 56 words ▾

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening

🧪 Active Ingredient 95 words ▾

ACTIVE INGREDIENTS: Adenoviren Nosode 15C, 30C, Asclepias Tuberosa 3X, Calcarea Arsenicica 12X, Camphora 12X, Coxsackie A2 Nosode 9C, Coxsackie A3 Nosode 9C, Coxsackie A4 Nosode 9C, Coxsackie A5 Nosode 15C, Coxsackie A7 Nosode 9C, Coxsackie B1 Nosode 9C, Coxsackie B3 Nosode 9C, Coxsackie B4 Nosode 18C, Coxsackie B5 Nosode 9C, Cytomegalovirus Nosode 15X, 30X, 60X, Echinacea Purpurea 3X, Epstein-Barr Virus Nosode 15C, 30C, Euphrasia Officinalis 6X, Influenzinum 12C, 30C, 60C, Lac Vaccinum 6X, Morbillinum 16X, 30X, 60X, Natrum Muriaticum 4X, Phytolacca Decandra 4X, Thuja Occidentalis 6X, 12X, 30X, Trifolium Pratense 3X, Variolinum 16X, 30X, 60X.

🧪 Inactive Ingredients 8 words ▾

INACTIVE INGREDIENTS: Alcohol USP 20%, Purified Water USP.

🎯 Purpose ~1 min read ▾

PURPOSE: Adenoviren Nosode – Chills, Occasional Headaches, and Runny Nose,† Asclepias Tuberosa – Occasional Headaches,† Calcarea Arsenicica – Chills and Occasional Headaches,† Camphora – Chills and Sweats,† Coxsackie A2 Nosode – Chills, Sweats, and Runny Nose,† Coxsackie A3 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie A4 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie A5 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie A7 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie B1 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie B3 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie B4 Nosode - Chills, Sweats, and Runny Nose,† Coxsackie B5 Nosode - Chills, Sweats, and Runny Nose,† Cytomegalovirus Nosode – Minor Aches of Muscles and Joints, and Runny Nose,† Echinacea Purpurea – Chills and Sweats,† Epstein-Barr Virus Nosode – Chills, Sweats, Occasional Headaches, and Minor Aches of Muscles and Joints,† Euphrasia Officinalis – Occasional Headaches and Runny Nose,† Influenzinum – Chills, Sweats, and Minor Aches of Muscles and Joints,† Lac Vaccinum – Minor Aches of Muscles and Joints,† Morbillinum – Runny Nose,† Natrum Muriaticum – Occasional Headaches and Runny Nose,† Phytolacca Decandra – Minor Aches of Muscles and Joints,† Thuja Occidentalis – Occasional Headaches and Minor Aches of Joints,† Trifolium Pratense – Chills and Occasional Headaches,† Variolinum – Chills, Sweats and Occasional Headaches† †Claims based on traditional homeopathic practice, not accepted medical evidence.

Not FDA evaluated.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Noso NDCsSame ingredient 🏭 All Nutritional labeler NDCsLabeler code 83027 📚 All Live Human Adenovirus Type 4 Vaccine NDCsDrug class